Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module
- PMID: 30176295
- PMCID: PMC6363826
- DOI: 10.1016/j.jaip.2018.08.013
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module
Abstract
Background: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but severe hypersensitivity reaction that remains poorly characterized in the United States.
Objective: To identify and describe DRESS syndrome cases in an integrated health care system using electronic health record (EHR) allergy module free-text searches.
Methods: We identified DRESS syndrome cases with rash, absolute eosinophil count of 500/L or more, organ involvement, and a European Registry of Severe Cutaneous Adverse Reactions to Drugs and Collection of Biological Samples score of 2 or more by reviewing those patients from 1980 to 2016 whose EHR allergic reaction matched DRESS-related key words. Liver injury required alanine aminotransferase level of 100 U/L or more, and renal injury required creatinine increase by 0.5 mg/dL (or 50%) or more. Patient and DRESS characteristics were described, resource use was determined, and cost was estimated.
Results: Among 3,162,562 patients with 3,319,387 million allergy entries, 538 reactions matched key words, and 69 were DRESS syndrome cases (prevalence 2.18 per 100,000). Patients with DRESS had liver (42%) or renal (42%) injury; 11 (16%) had both liver and renal injury. Primary drug culprits were antibiotics (74%) (vancomycin [39%], β-lactams [23%], fluoroquinolones [4%], tetracyclines [4%], and sulfonamides [3%]) and anticonvulsants (20%). Of 65 (94%) hospitalized patients with DRESS, 43 (66%) were hospitalized for DRESS syndrome management with median length of stay of 9 days (interquartile range, 6-17 days) and cost approximately $17,101 per patient.
Conclusions: Using free-text search of the EHR allergy module identified a large US DRESS syndrome cohort. DRESS prevalence was 2.18 per 100,000 patients. Both liver and kidney injury were frequent, and vancomycin was the most common drug culprit. DRESS cases were morbid and resource-intensive.
Keywords: Anticonvulsant hypersensitivity syndrome; Cost; Drug-induced hypersensitivity syndrome; Hypersensitivity; Resource; Severe cutaneous adverse reaction.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest:
NAP discloses spousal employment by Chiesi Farmaceutici; this is unrelated to the submitted manuscript.
The other authors (ARW, LZ, YL, OAC, KGB) declare no conflict of interest.
Figures

Similar articles
-
Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics.J Allergy Clin Immunol. 2015 Nov;136(5):1288-94.e1. doi: 10.1016/j.jaci.2015.04.005. Epub 2015 May 14. J Allergy Clin Immunol. 2015. PMID: 25981739 Free PMC article.
-
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.Allergol Int. 2016 Oct;65(4):432-438. doi: 10.1016/j.alit.2016.04.001. Epub 2016 Apr 28. Allergol Int. 2016. PMID: 27134114
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study.Br J Clin Pharmacol. 2022 Sep;88(9):4134-4141. doi: 10.1111/bcp.15354. Epub 2022 Apr 26. Br J Clin Pharmacol. 2022. PMID: 35421262
-
Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome.J Investig Allergol Clin Immunol. 2020;30(4):229-253. doi: 10.18176/jiaci.0480. Epub 2020 Jan 14. J Investig Allergol Clin Immunol. 2020. PMID: 31932268 Review.
-
Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review.Biomed Res Int. 2019 Sep 24;2019:7863815. doi: 10.1155/2019/7863815. eCollection 2019. Biomed Res Int. 2019. PMID: 31662996 Free PMC article.
Cited by
-
Reactivation of Human Herpesvirus (HHV) 6 as Etiology of Acute Liver Injury in Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report.Cureus. 2022 Sep 28;14(9):e29697. doi: 10.7759/cureus.29697. eCollection 2022 Sep. Cureus. 2022. PMID: 36321059 Free PMC article.
-
Trimethoprim-Sulfamethoxazole-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Complicated by Acute Liver Failure.Cureus. 2022 Oct 29;14(10):e30852. doi: 10.7759/cureus.30852. eCollection 2022 Oct. Cureus. 2022. PMID: 36457619 Free PMC article.
-
Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases.Front Immunol. 2024 Dec 16;15:1490334. doi: 10.3389/fimmu.2024.1490334. eCollection 2024. Front Immunol. 2024. PMID: 39737180 Free PMC article.
-
Literature review of the clinical features of sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS).Front Pharmacol. 2024 Dec 2;15:1488483. doi: 10.3389/fphar.2024.1488483. eCollection 2024. Front Pharmacol. 2024. PMID: 39687296 Free PMC article.
-
Case Report: Alpelisib-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Rare Manifestation of a Common Side Effect.Front Oncol. 2021 Aug 24;11:726785. doi: 10.3389/fonc.2021.726785. eCollection 2021. Front Oncol. 2021. PMID: 34504802 Free PMC article.
References
-
- Myers GB, Heide EV, Balcerski M. Exfoliative dermatitis following sulfanilamide. JAMA 1937;109:1983–1984.
-
- Saltzstein SL, Ackerman LV. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphomas. Cancer 1959;12:164–182. - PubMed
-
- Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 2010;146:1373–1379. - PubMed
-
- Um SJ, Lee SK, Kim YH, Kim KH, Son CH, Roh MS, et al. Clinical features of drug-induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol 2010;20:556–562. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources